naltrexone has been researched along with Autistic Disorder in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (16.67) | 18.7374 |
1990's | 35 (64.81) | 18.2507 |
2000's | 9 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (1.85) | 2.80 |
Authors | Studies |
---|---|
Sablaban, IM; Sivananthan, M | 1 |
Contejean, Y; Desjardins, S; Doyen, C; Kaye, K; Paubel, P | 1 |
Delaney, MA; Gratz, SS; Hyman, SB; Malone, RP | 1 |
Augusto, LM; Elchaar, GM; Maisch, NM; Wehring, HJ | 1 |
Good, P | 1 |
Buitelaar, JK; Nijhof, GJ; van England, H; Willemsen-Swinkels, SH | 1 |
Klimesch, W; Klingler, D; Lensing, P; Panksepp, J; Pap, V; Schimke, H; Szemes, G | 1 |
Adams, PB; Bluhm, LD; Campbell, M; Foltz, RL; Gonzalez, NM; Shay, J; Small, AM | 1 |
Gillberg, C | 1 |
Feldman, HM; Handen, BL; Janosky, JE; Kolmen, BK | 2 |
Benjamin, S; Gagnon, M; Price, E; Seek, A; Tresise, L | 1 |
Black, SL | 1 |
Adams, P; Anderson, LT; Campbell, M; Ernst, M; Gonzalez, NM; Small, AM | 1 |
Campbell, M; Devi, L; Ernst, M; Gonzalez, NM; Malone, RP; Silva, RR; Small, AM | 1 |
Bondoux, D; Bouvard, MP; Dugas, M; Launay, JM; Leboyer, M; Lensing, P; Plumet, MH; Recasens, C; Tabuteau, F; Waller-Perotte, D | 1 |
Buitelaar, JK; van Engeland, H; Weijnen, FG; Willemsen-Swinkels, SH | 1 |
Compagnon, M; Decocq, G; Kandelaft, N | 1 |
Campbell, M; Cueva, JE; Hallin, A; Schopler, E | 1 |
Campbell, M; Harris, JC | 1 |
Buitelaar, JK; van Engeland, H; Willemsen-Swinkels, SH | 1 |
Adesman, AR | 1 |
Batticane, N; Cioni, M; Gallo, F; Marchetti, B; Morale, MC; Nicolosi, A; Quattropani, MC; Scifo, R; Testa, N; Tirolo, C | 1 |
Calandra, C; Marchetti, B; Parrinello, MA; Scifo, R | 1 |
Buitelaar, JK; Van Engeland, H; Willemsen-Swinkels, S | 1 |
Blatt, SD; Botash, AS; Church, CC; Jean-Louis, F; Meguid, V; Siripornsawan, MP; Weinberger, HL | 1 |
Bernstein, GA; Cook, EH; Leonard, HL; March, JS; Riddle, MA; Swanson, JM | 1 |
Feldman, HM; Gonzaga, AM; Kolmen, BK | 1 |
Buitelaar, JK; van Berckelaer-Onnes, IA; van Engeland, H; Willemsen-Swinkels, SH | 1 |
Bajo, S; Cazzullo, AG; Musetti, L; Musetti, MC; Panerai, A; Sacerdote, P | 1 |
Chicz-DeMet, A; Hetrick, W; Marion, S; Sandman, CA; Talyor, D | 1 |
Hunsinger, DM; Nguyen, T; Raffa, RB; Zebraski, SE | 1 |
Chabane, N; Leboyer, M; Mouren-Simeoni, MC | 1 |
McDougle, CJ; Posey, DJ | 1 |
Allard, A; Bloom, AS; Dalrymple, N; Sears, L; Williams, PG | 1 |
Adam, H; Hackenberg, B; Huber, M; Klingler, D; Lensing, P; Panksepp, J; Saria, A | 1 |
Bouvard, MP; Dugas, M; Kerdelhue, B; Launay, JM; Leboyer, M; Lensing, P; Panksepp, J; Tabuteau, F; Waller, D | 1 |
Bouvard, M; Klingler, D; Lampl, C; Leboyer, M; Lensing, P; Panksepp, J; Plumet, MH | 1 |
Chicz-DeMet, A; Ellman, G; Heidorn, S; Hom, A; Wymore, M; Zingarelli, G | 1 |
Sloman, L | 1 |
Barron, JL; Hetrick, WP; Neri, CL; Sandman, CA; Taylor, DV; Touchette, P | 1 |
Lensing, P; Panksepp, J | 1 |
Barrett, RP; Feinstein, C; Hole, WT; Mercurio, A; Walters, AS | 1 |
Anderson, LT; Campbell, M; Choroco, MC; Locascio, JJ; Lynch, NS; Small, AM | 1 |
Knabe, R; Richard, J; Schulz, P | 1 |
Sandman, CA | 1 |
Lienemann, J; Walker, F | 1 |
Barrett, RP; Feinstein, C; Hole, WT | 1 |
Appelgate, K; Arthur-Smith, A; Hammock, MK; Herman, BH; Kuehl, K | 1 |
Bouvard, MP; Dugas, M; Leboyer, M | 1 |
Adams, P; Campbell, M; Foltz, RL; Monti, KM; Nobler, M; Overall, JE; Perry, R; Small, AM; Sokol, MS; Spencer, EK | 1 |
Panksepp, J; Sahley, TL | 1 |
Adams, P; Campbell, M; Curren, EL; Small, AM; Tesch, LM | 1 |
Thompson, DF; Thompson, GD | 1 |
10 review(s) available for naltrexone and Autistic Disorder
Article | Year |
---|---|
Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.
Topics: Adolescent; Adrenergic alpha-Agonists; Antipsychotic Agents; Autistic Disorder; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Humans; Naltrexone; Nutrition Therapy; Selective Serotonin Reuptake Inhibitors; Vitamins | 2005 |
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
Topics: Autistic Disorder; Child; Clinical Trials as Topic; Humans; Naltrexone; Narcotic Antagonists; Self-Injurious Behavior | 2006 |
Treatment of autistic disorder.
Topics: Antipsychotic Agents; Autistic Disorder; Behavior Therapy; Clomipramine; Clonidine; Fenfluramine; Humans; Naltrexone; Rehabilitation, Vocational; Selective Serotonin Reuptake Inhibitors; Speech Therapy | 1996 |
Sudden infant death syndrome, child sexual abuse, and child development.
Topics: Autistic Disorder; Child; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Fluoxetine; Humans; Infant; Infant, Newborn; Naltrexone; Narcotic Antagonists; Papillomaviridae; Papillomavirus Infections; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sudden Infant Death | 1999 |
Anxiolytics, adrenergic agents, and naltrexone.
Topics: Adolescent; Adolescent Psychiatry; Adrenergic Agonists; Anti-Anxiety Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Psychiatry; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Treatment Outcome | 1999 |
Is there a basis for novel pharmacotherapy of autism?
Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Autistic Disorder; Buspirone; Dietary Supplements; Humans; Immunoglobulins, Intravenous; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Risperidone; Secretin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2000 |
Opiate antagonists in children and adolescents.
Topics: Adolescent; Adolescent Psychiatry; Alcoholism; Autistic Disorder; Child; Feeding and Eating Disorders; Female; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists | 2000 |
Pharmacotherapeutic management of autism.
Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Autistic Disorder; Central Nervous System Stimulants; Humans; Naltrexone; Selective Serotonin Reuptake Inhibitors | 2001 |
[Opiate hypothesis of the origin of early childhood autism and sequelae for psychopharmacotherapy].
Topics: Autistic Disorder; Brain; Child; Endorphins; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid | 1992 |
Use of medication in pervasive developmental disorders.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Development Disorders, Pervasive; Fenfluramine; Humans; Methylphenidate; Naltrexone; Psychotropic Drugs | 1991 |
23 trial(s) available for naltrexone and Autistic Disorder
Article | Year |
---|---|
Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
Topics: Adolescent; Adult; Autistic Disorder; Comorbidity; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Intellectual Disability; Male; Middle Aged; Naltrexone; Placebos; Psychiatric Status Rating Scales; Self-Injurious Behavior; Stereotyped Behavior; Treatment Outcome | 1995 |
Naltrexone plasma levels, clinical response and effect on weight in autistic children.
Topics: Autistic Disorder; Body Weight; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Naltrexone; Treatment Outcome | 1994 |
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.
Topics: Autistic Disorder; Child; Child, Preschool; Communication; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Naltrexone; Personality Assessment; Social Behavior | 1995 |
Naltrexone in autistic children: behavioral symptoms and attentional learning.
Topics: Attention; Autistic Disorder; Child; Child, Preschool; Discrimination Learning; Female; Humans; Male; Naltrexone; Psychiatric Status Rating Scales; Self-Injurious Behavior; Severity of Illness Index; Stereotyped Behavior; Treatment Outcome; Weight Loss | 1993 |
Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
Topics: Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Double-Blind Method; Female; Haloperidol; Humans; Male; Naltrexone | 1993 |
Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.
Topics: Adolescent; Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Neurotransmitter Agents; Personality Assessment | 1995 |
Placebo-controlled acute dosage naltrexone study in young autistic children.
Topics: Attention; Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Personality Assessment; Social Behavior | 1995 |
Resolved: autistic children should have a trial of naltrexone.
Topics: Autistic Disorder; Child; Child, Preschool; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Placebos | 1996 |
The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
Topics: Autistic Disorder; Child; Child, Preschool; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Personality Assessment; Social Behavior; Treatment Outcome | 1996 |
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.
Topics: Adolescent; Antigens, CD; Autistic Disorder; Behavior; beta-Endorphin; Child; Cross-Over Studies; Double-Blind Method; Female; Humans; Lymphocyte Subsets; Male; Naltrexone; Narcotic Antagonists | 1996 |
Naltrexone in young autistic children: replication study and learning measures.
Topics: Attention; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Child; Child, Preschool; Communication; Cross-Over Studies; Female; Humans; Learning; Male; Naltrexone; Narcotic Antagonists; Self Stimulation; Treatment Outcome | 1997 |
Naltrexone and communication skills in young children with autism.
Topics: Autistic Disorder; Child; Child, Preschool; Cross-Over Studies; Double-Blind Method; Female; Humans; Language; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Parent-Child Relations; Treatment Outcome; Verbal Behavior | 1999 |
Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child, Preschool; Female; Humans; Interpersonal Relations; Male; Naltrexone; Social Adjustment | 1999 |
Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children.
Topics: Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Cognition; Humans; Leukocytes, Mononuclear; Naltrexone; Narcotic Antagonists; Stereotyped Behavior | 1999 |
Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management.
Topics: Attention; Autistic Disorder; Case-Control Studies; Child; Child Behavior Disorders; Child, Preschool; Double-Blind Method; Humans; Male; Naltrexone; Personality Assessment; Social Behavior | 2001 |
Brief report: a double-blind study of naltrexone in infantile autism.
Topics: Adolescent; Arginine Vasopressin; Autistic Disorder; beta-Endorphin; Child; Child, Preschool; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Female; Humans; Male; Naltrexone; Norepinephrine | 1992 |
Clinical effects of naltrexone on autistic behavior.
Topics: Adult; Aggression; Autistic Disorder; Double-Blind Method; Female; Humans; Institutionalization; Male; Naltrexone; Self-Injurious Behavior; Stereotyped Behavior | 1992 |
A case report of naltrexone treatment of self-injury and social withdrawal in autism.
Topics: Adolescent; Autistic Disorder; Clinical Trials as Topic; Double-Blind Method; Humans; Intellectual Disability; Interpersonal Relations; Male; Naltrexone; Self Mutilation; Social Adjustment; Stereotyped Behavior | 1990 |
Naltrexone in autistic children: a double-blind and placebo-controlled study.
Topics: Autistic Disorder; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Naltrexone; Randomized Controlled Trials as Topic | 1990 |
Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.
Topics: Adult; Autistic Disorder; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Naltrexone; Self Mutilation | 1990 |
Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis.
Topics: Adult; Autistic Disorder; beta-Endorphin; Clinical Trials as Topic; Developmental Disabilities; Homeostasis; Humans; Male; Naloxone; Naltrexone | 1988 |
Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.
Topics: Autistic Disorder; Child; Clinical Trials as Topic; Conditioning, Operant; Double-Blind Method; Extinction, Psychological; Female; Half-Life; Humans; Naloxone; Naltrexone; Reinforcement Schedule; Self Mutilation | 1989 |
Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Autistic Disorder; Blood Pressure; Body Temperature; Body Weight; Child; Child, Preschool; Electrocardiography; Enzymes; Female; Heart Rate; Hemodynamics; Humans; Male; Naltrexone | 1989 |
21 other study(ies) available for naltrexone and Autistic Disorder
Article | Year |
---|---|
Topics: Autistic Disorder; Child; Compulsive Behavior; Humans; Male; Naltrexone; Narcotic Antagonists; Sexual Behavior | 2020 |
[Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form].
Topics: Administration, Oral; Autistic Disorder; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Education, Special; France; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Care Team; Physical Therapy Modalities; Psychomotor Disorders; Speech Therapy; Suspensions; Treatment Outcome | 2009 |
Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?
Topics: Anti-Inflammatory Agents; Autistic Disorder; Dose-Response Relationship, Drug; Humans; Models, Biological; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Nitric Oxide Synthase Type II | 2006 |
Clinical case report: opiate antagonist and event-related desynchronization in 2 autistic boys.
Topics: Alpha Rhythm; Autistic Disorder; Cerebral Cortex; Child; Cortical Synchronization; Humans; Light; Male; Naltrexone; Neural Pathways; Opioid Peptides; Pursuit, Smooth; Thalamus; Visual Perception | 1995 |
Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.
Topics: Autistic Disorder; Brain; Endorphins; Humans; Infant, Newborn; Melatonin; Naloxone; Naltrexone; Self-Injurious Behavior; Serotonin | 1995 |
Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
Topics: Adult; Autistic Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Intellectual Disability; Male; Naltrexone; Self-Injurious Behavior | 1995 |
Naltrexone in infantile autism.
Topics: Autistic Disorder; beta-Endorphin; Child; Humans; Long-Term Care; Naltrexone | 1994 |
[Effects of naltrexone on automutilation behavior in autistic psychosis].
Topics: Adult; Autistic Disorder; Humans; Male; Naltrexone; Narcotic Antagonists; Self Mutilation | 1996 |
Hyperactivity and ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Comorbidity; Diagnosis, Differential; Humans; Hyperkinesis; Naltrexone; Narcotic Antagonists | 1996 |
Prognostic significance of depression occurrence in infantile autism.
Topics: Adolescent; Antidepressive Agents; Autistic Disorder; Child; Depressive Disorder; Humans; Male; Naltrexone; Prognosis | 1996 |
Naltrexone in children with autism.
Topics: Adult; Autistic Disorder; Behavioral Symptoms; Child; Controlled Clinical Trials as Topic; Humans; Naltrexone; Narcotic Antagonists; Outcome Assessment, Health Care | 1998 |
Uncoupling of proopiomelanocortin (POMC) fragments is related to self-injury.
Topics: Adrenocorticotropic Hormone; Autistic Disorder; beta-Endorphin; Humans; Naltrexone; Narcotic Antagonists; Peptide Fragments; Pro-Opiomelanocortin; Self-Injurious Behavior | 2000 |
Naltrexone open trial with a 5-year-old-boy. A social rebound reaction.
Topics: Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child, Preschool; Humans; Intellectual Disability; Male; Naltrexone; Personality Assessment; Social Behavior | 1992 |
Effect of naltrexone upon self-injurious behavior, learning and activity: a case study.
Topics: Adult; Autistic Disorder; Cognition; Humans; Hypnotics and Sedatives; Intellectual Disability; Learning; Male; Memory; Microcephaly; Motor Activity; Naltrexone; Self-Injurious Behavior | 1991 |
Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.
Topics: Adolescent; Aggression; Attention; Autistic Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intellectual Disability; Male; Motor Activity; Naltrexone; Social Behavior; Social Environment | 1991 |
Naltrexone for treatment of self-injury.
Topics: Adult; Autistic Disorder; Female; Humans; Naltrexone; Self Mutilation | 1989 |
Effects on naltrexone on infantile autism.
Topics: Autistic Disorder; Child; Child Behavior; Drug Administration Schedule; Female; Humans; Naltrexone | 1988 |
Naltrexone in autistic children: an acute open dose range tolerance trial.
Topics: Autistic Disorder; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Male; Naltrexone; Stereotyped Behavior | 1989 |
Brain opioids and autism: an updated analysis of possible linkages.
Topics: Autistic Disorder; Brain; Brain Damage, Chronic; Child; Emotions; Endorphins; Humans; Language Development Disorders; Naloxone; Naltrexone; Receptors, Opioid; Serotonin; Social Behavior | 1987 |
Naltrexone in infantile autism.
Topics: Autistic Disorder; Child; Child, Preschool; Humans; Male; Naltrexone | 1988 |
Naltrexone in the management of seizures associated with Rett syndrome.
Topics: Autistic Disorder; Female; Gait; Humans; Naltrexone; Seizures; Syndrome | 1987 |